Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cellsBrian G. Till, Oliver W. Press, Brent L. Wood et al.|Blood|2008Cited by 719
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial resultsBrian G. Till, Oliver W. Press, Michael C. Jensen et al.|Blood|2012Cited by 530
PTEN inhibitor improves vascular remodeling and cardiac function after myocardial infarction through PI3k/Akt/VEGF signaling pathwayQiuting Feng, Xiaojun Qian|Molecular Medicine|2020Cited by 61